Bioconversion From Docosahexaenoic Acid to Eicosapentaenoic Acid in the Marine Bacterium Shewanella livingstonensis Ac10

by Takuya Ogawa, Kazuki Hirose, Yustina Yusuf, Jun Kawamoto, Tatsuo Kurihara
Published 2020-05-01

Drug‐induced interstitial lung disease associated with dasatinib coinciding with active tuberculosis

by Nozomi Tani, Yusuke Kunimatsu, Izumi Sato, Yuri Ogura, Kazuki Hirose, Takayuki Takeda
Published 2020-10-01

Improvement in Subjective Symptoms and Tolerability in Response to Nintedanib Treatment in Elderly Patients with Idiopathic Pulmonary Fibrosis

by Takayuki Takeda, Yusuke Kunimatsu, Nozomi Tani, Izumi Hashimoto, Yuri Kurono, Kazuki Hirose
Published 2020-03-01

IgG4‐related lung disease progressing to respiratory failure

by Yusuke Kunimatsu, Nozomi Tani, Izumi Sato, Yuri Ogura, Kazuki Hirose, Takayuki Takeda
Published 2020-10-01

Vogt–Koyanagi–Harada disease during chemoimmunotherapy for non‐small cell lung cancer

by Yuri Kurono, Takayuki Takeda, Yusuke Kunimatsu, Nozomi Tani, Izumi Hashimoto, Kazuki Hirose
Published 2020-04-01

Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer

by Nobutaka Kataoka, Yusuke Kunimatsu, Yusuke Tachibana, Takumi Sugimoto, Izumi Sato, Nozomi Tani, Yuri Ogura, Kazuki Hirose, Takayuki Takeda
Published 2020-09-01

Osimertinib-Associated Toxic Epidermal Necrolysis in a Lung Cancer Patient Harboring an EGFR Mutation—A Case Report and a Review of the Literature

by Izumi Sato, Hiroki Mizuno, Nobutaka Kataoka, Yusuke Kunimatsu, Yusuke Tachibana, Takumi Sugimoto, Nozomi Tani, Yuri Ogura, Kazuki Hirose, Takayuki Takeda
Published 2020-08-01

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation

by Akihiro Yoshimura, Tadaaki Yamada, Naoko Okura, Takayuki Takeda, Kazuki Hirose, Yutaka Kubota, Shinsuke Shiotsu, Osamu Hiranuma, Yusuke Chihara, Nobuyo Tamiya, Yoshiko Kaneko, Junji Uchino, Koichi Takayama
Published 2019-03-01

Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR‐mutated non‐small cell lung cancer

by Tadaaki Yamada, Soichi Hirai, Yuki Katayama, Akihiro Yoshimura, Shinsuke Shiotsu, Satoshi Watanabe, Toshiaki Kikuchi, Kazuki Hirose, Yutaka Kubota, Yusuke Chihara, Taishi Harada, Keiko Tanimura, Takayuki Takeda, Nobuyo Tamiya, Yoshiko Kaneko, Junji Uchino, Koichi Takayama
Published 2019-04-01